Palo Alto Investors’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$735K Hold
2025
Q1
$704K Hold
2024
Q4
$1.49M Hold
2024
Q3
$837K Hold
2024
Q2
$878K Hold
2024
Q1
$1.37M Hold
2023
Q4
$1.04M Buy